Eden Health GLP-1 vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Eden Health GLP-1 beats Hers overall, scoring 8.9/10 vs 7.3/10. Hers is more affordable at $199/mo vs $249/mo. Choose Eden Health GLP-1 for people with diabetes, heart conditions, or other risk factor. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of Eden Health GLP-1 and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Eden Health GLP-1

#1 of 48

8.9/10

Premium online weight-loss program from Eden Health (San Francisco, founded 2021). Different from competitors in one specific way: every patient is paired with a board-certified obesity medicine doctor (a doctor with specialized training in weight and metabolism), not a general practitioner or nurse. Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly cost. Eden prescribes both compounded GLP-1s (custom-made versions, not the FDA-approved brand) and brand-name Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Eden Health GLP-1

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	Eden Health GLP-1	Hers
Our Score	8.9/10	7.3/10
Starting Price	$249/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	People with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their GLP-1 — with blood panels included.	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#1	#35

Pros & Cons Compared

Eden Health GLP-1

Pros

+4.5 stars across 3,777 verified Trustpilot reviews — 77% give 5 stars. Replies to 99% of negative reviews. The strongest customer-experience signal of any provider in our table.
+Doctors are board-certified obesity medicine specialists — not general practitioners. Specialized training in weight and metabolism.
+Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly price. Most competitors don't include labs.
+Mandatory check-in with the doctor before each dose increase. Won't rush you up the ladder.
+Full medication choice: compounded semaglutide/tirzepatide AND brand-name Wegovy, Zepbound, Ozempic, Mounjaro.

Cons

−$249/mo ongoing (month-to-month) is on the high end. Henry Meds is $199/mo for similar compounded care without labs; MEDVi is $179/mo.
−Cash-pay only — no insurance billing.
−Cancellation friction is the main 1-star Trustpilot complaint (13% of reviews). Some users report being billed or shipped after they canceled.
−Their website is not always user-friendly — multiple Trustpilot users mention they had to contact support to make payment or account changes.
−Pharmacy partner not named specifically — 'state-licensed compounding pharmacies' in their marketing, but no individual facility named.

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

Eden Health GLP-1 edges out Hers with a score of 8.9/10 vs 7.3/10. If budget is your priority, Hers starts at $199/mo compared to Eden Health GLP-1's $249/mo. Choose Eden Health GLP-1 if you want: people with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their glp-1 — with blood panels included.. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Eden Health GLP-1 nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review